Proteome analysis of multidrug-resistant, breast cancer-derived microparticles

Journal of Extracellular Vesicles

Volumn 3, Issue 1, 2014, Pages

  Pokharel, Deep ^a   Padula, Matthew P ^a,b   Lu, Jamie F ^a   Tacchi, Jessica L ^b   Luk, Frederick ^a   Djordjevic, Steven P ^a,b   Bebawy, Mary ^a  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

Breast cancer; Liquid chromatography tandem mass spectrometry; Microparticles; Multidrug resistance; P glycoprotein; Proteomics; Tissue selectivity

Indexed keywords

CYTOSKELETON PROTEIN; EZRIN; HERMES ANTIGEN; MOESIN; MULTIDRUG RESISTANCE PROTEIN; RADIXIN;

ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; LIQUID CHROMATOGRAPHY; MEMBRANE MICROPARTICLE; MULTIDRUG RESISTANCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; PROTEIN TRANSPORT; PROTEOMICS; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

EID: 85014113657     PISSN: None     EISSN: 20013078     Source Type: Journal    
DOI: 10.3402/jev.v3.24384     Document Type: Article

References (71)

1. Biedler JL, Riehm H, Peterson RH, Spengler BA. Membranemediated drug resistance and phenotypic reversion to normal growth behavior of Chinese hamster cells. J Natl Cancer Inst. 1975;55:671-80.
2. Fojo A, Akiyama S, Gottesman MM, Pastan I. Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines. Cancer Res. 1985;45:3002-7.
3. Riordan JR, Deuchars K, Kartner N, Alon N, Trent J, Ling V. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines. Nature. 1985;316:817-9. doi: 10.1038/316817a0.
4. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer. 2002;2:48-58.
5. Levchenko A, Mehta BM, Niu X, Kang G, Villafania L, Way D, et al. Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells. Proc Natl Acad Sci USA. 2005;102:1933-8.
6. Bebawy M, Combes V, Lee E, Jaiswal R, Gong J, Bonhoure A, et al. Membrane microparticles mediate transfer of Pglycoprotein to drug sensitive cancer cells. Leukemia. 2009; 23:1643-9.
7. Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654-9.
8. Bergsmedh A, Szeles A, Henriksson M, Bratt A, Folkman MJ, Spetz A-L, et al. Horizontal transfer of oncogenes by uptake of apoptotic bodies. Proc Natl Acad Sci USA. 2001;98:6407-11.
9. Watkins SC, Salter RD. Functional connectivity between immune cells mediated by tunneling nanotubules. Immunity. 2005;23:309-18.
10. Sherer NM, Mothes W. Cytonemes and tunneling nanotubules in cell-cell communication and viral pathogenesis. Trends Cell Biol. 2008;18:414-20.
11. Jaiswal R, Gong J, Sambasivam S, Combes V, Mathys J-M, Davey R, et al. Microparticle-associated nucleic acids mediate trait dominance in cancer. FASEB J. 2012;26:420-9.
12. Bebawy M, Morris MB, Roufogalis BD. A continuous fluorescence assay for the study of P-glycoprotein-mediated drug efflux using inside-out membrane vesicles. Anal Biochem. 1999;268:270-7.
13. Jaiswal R, Luk F, Dalla PV, Grau GER, Bebawy M. Breast cancer-derived microparticles display tissue selectivity in the transfer of resistance proteins to cells. PLoS One. 2013;8:e61515.
14. Distler JH, Pisetsky DS, Huber LC, Kalden JR, Gay S, Distler O. Microparticles as regulators of inflammation: novel players of cellular crosstalk in the rheumatic diseases. Arthritis Rheum. 2005;52:3337-48.
15. Gong J, Jaiswal R, Mathys J-M, Combes V, Grau G, Bebawy M. Microparticles and their emerging role in cancer multidrug resistance. Cancer Treat Rev. 2012;38:226-34.
16. Zwicker JI, Liebman HA, Neuberg D, Lacroix R, Bauer KA, Furie BC, et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res. 2009;15:6830-40.
17. Vasina E, Heemskerk JW, Weber C, Koenen RR. Platelets and platelet-derived microparticles in vascular inflammatory disease. Inflamm Allergy Drug Targets. 2010;9:346-54.
18. Sabatier F, Darmon P, Hugel B, Combes V, Sanmarco M, Velut J-G, et al. Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. Diabetes. 2002;51:2840-5.
19. Mack M, Kleinschmidt A, Brühl H, Klier C, Nelson PJ, Cihak J, et al. Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: a mechanism for cellular human immunodeficiency virus 1 infection. Nat Med. 2000;6:769-75.
20. Nieuwland R, van der Post JA, Lok CA, Kenter G, Sturk A, editors. Microparticles and exosomes in gynecologic neoplasias. Semin Thromb Hemost. 2010;36:925-9.
21. Jeon S, Kim NH, Kim JY, Lee AY. Stem cell factor induces ERM proteins phosphorylation through PI3K activation to mediate melanocyte proliferation and migration. Pigment Cell Melanoma Res. 2009;22:77-85.
22. Luciani F, Molinari A, Lozupone F, Calcabrini A, Lugini L, Stringaro A, et al. P-glycoprotein-actin association through ERM family proteins: a role in P-glycoprotein function in human cells of lymphoid origin. Blood. 2002;99:641-8.
23. Killock DJ, Parsons M, Zarrouk M, Ameer-Beg SM, Ridley AJ, Haskard DO, et al. In vitro and in vivo characterization of molecular interactions between calmodulin, ezrin/radixin/moesin, and L-selectin. J Biol Chem. 2009;284:8833-45.
24. Lu JF, Luk F, Gong J, Jaiswal R, Grau GE, Bebawy M. Microparticles mediate MRP1 intercellular transfer and the retemplating of intrinsic resistance pathways. Pharmacol Res. 2013;76:77-83.
25. Gong J, Luk F, Jaiswal R, George AM, Grau GER, Bebawy M. Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistance. Eur J Pharmacol. 2013;721:116-25.
26. Jaiswal R, Luk F, Gong J, Mathys J-M, Grau G, Bebawy M. Microparticle conferred microRNA profiles-implications in the transfer and dominance of cancer traits. Mol Cancer. 2012; 11:37.
27. Bogema DR, Deutscher AT, Woolley LK, Seymour LM, Raymond BB, Tacchi JL, et al. Characterization of cleavage events in the multifunctional cilium adhesin Mhp684 (P146) reveals a mechanism by which Mycoplasma hyopneumoniae regulates surface topography. MBio. 2012;3:e00282-11.
28. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probabilitybased protein identification by searching sequence databases using mass spectrometry data. Electrophoresis. 1999;20(18): 3551-67.
29. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem. 2002; 74:5383-92.
30. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometrym. Anal Chem. 2003;75:4646-58.
31. Andaloussi SE, Mäger I, Breakefield XO, Wood MJ. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12:347-57.
32. Lloubes R, Bernadac A, Pommier S. Non classical secretion systems. Res Microbiol. 2013;164:655-63.
33. Lee Y, Andaloussi SE, Wood MJ. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet. 2012;21:R125-34.
34. Kucharzewska P, Belting M. Emerging roles of extracellular vesicles in the adaptive response of tumour cells to microenvironmental stress. J Extracell Vesicles 2013;2:20304, doi: http://dx.doi.org/10.3402/jev.v2i0.20304.
35. Dvorak H, Quay S, Orenstein N, Dvorak A, Hahn P, Bitzer A, et al. Tumor shedding and coagulation. Science. 1981;212:923-4.
36. Al-Nedawi K, Meehan B, Kerbel RS, Allison AC, Rak J. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR. Proc Natl Acad Sci USA. 2009;106:3794-9.
37. Zöller M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat Rev Cancer. 2011;11: 254-67.
38. Wang L, Zhou X, Zhou T, Ma D, Chen S, Zhi X, et al. Ecto-5'-nucleotidase promotes invasion, migration and adhesion of human breast cancer cells. J Cancer Res Clin Oncol. 2008; 134:365-72.
39. Ujhazy P, Berleth ES, Pietkiewicz JM, Kitano H, Skaar JR, Ehrke MJ, et al. Evidence for the involvement of ecto-5'-nucleotidase (CD73) in drug resistance. Int J Cance. 1996; 68:493-500.
40. Kalinina E, Berozov T, Shtil A, Chernov N, Glasunova V, Novichkova M, et al. Expression of genes of glutathione transferase isoforms GSTP1-1, GSTA4-4, and GSTK1-1 in tumor cells during the formation of drug resistance to cisplatin. Bull Exp Biol Med. 2012;154:64-7.
41. Meurice N, Wang L, Lipinski CA, Yang Z, Hulme C, Loftus JC. Structural conservation in band 4.1, ezrin, radixin, moesin (FERM) domains as a guide to identify inhibitors of the proline-rich tyrosine kinase 2. J Med Chem. 2009;53:669-77.
42. Amieva MR, Furthmayr H. Subcellular localization of moesin in dynamic filopodia, retraction fibers, and other structures involved in substrate exploration, attachment, and cell-cell contacts. Exp Cell Res. 1995;219:180-96.
43. Pearson MA, Reczek D, Bretscher A, Karplus PA. Structure of the ERM protein moesin reveals the FERM domain fold masked by an extended actin binding tail domain. Cell. 2000; 101:259-70.
44. Dixon J, Kaklamanis L, Turley H, Hickson I, Leek R, Harris A, et al. Expression of aminopeptidase-n (CD 13) in normal tissues and malignant neoplasms of epithelial and lymphoid origin. J Clin Pathol. 1994;47:43-7.
45. Kuhajda FP. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition. 2000;16: 202-8.
46. Critchley D. Cytoskeletal proteins talin and vinculin in integrinmediated adhesion. Biochem Soc Trans. 2004;32:831-6.
47. ViéN, Copois V, Bascoul-Mollevi C, Denis V, Bec N, Robert B, et al. Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells. Mol Cancer. 2008;7:14.
48. Ghosh P, Anderson J, Cohen N, Takeshita K, Atweh G, Lebowitz P. Expression of the leukemia-associated gene, p18, in normal and malignant tissues; inactivation of expression in a patient with cleaved B cell lymphoma/leukemia. Oncogene. 1993;8:2869.
49. Vadlamudi RK, Li F, Adam L, Nguyen D, Ohta Y, Stossel TP, et al. Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1. Nat Cell Biol. 2002; 4:681-90.
50. Honda K, Yamada T, Endo R, Ino Y, Gotoh M, Tsuda H, et al. Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion. J Cell Biol. 1998;140:1383-93.
51. Geiger B, Spatz JP, Bershadsky AD. Environmental sensing through focal adhesions. Nat Rev Mol Cell Biol. 2009;10:21-33.
52. Miletti-González KE, Chen S, Muthukumaran N, Saglimbeni GN, Wu X, Yang J, et al. The CD44 receptor interacts with P-glycoprotein to promote cell migration and invasion in cancer. Cancer Res. 2005;65:6660-7.
53. Zhi X, Chen S, Zhou P, Shao Z, Wang L, Ou Z, et al. RNA interference of ecto-5'-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion. Clin Exp Metastasis. 2007;24:439-48.
54. Wang L, Tang S, Wang Y, Xu S, Yu J, Zhi X, et al. Ecto-5'-nucleotidase (CD73) promotes tumor angiogenesis. Clin Exp Metastasis. 2013;30:671-80.
55. Rappa G, Lorico A, Flavell RA, Sartorelli AC. Evidence that the multidrug resistance protein (MRP) functions as a cotransporter of glutathione and natural product toxins. Cancer Res. 1997;57:5232-7.
56. Fu D, Bebawy M, Kable EP, Roufogalis BD. Dynamic and intracellular trafficking of P-glycoprotein-EGFP fusion protein: implications in multidrug resistance in cancer. Int J Cancer. 2004;109:174-81.
57. Carreiras F, Lehmann M, Sichel F, Marvaldi J, Gauduchon P, Talaer L. Implication of the avb3 integrin in the adhesion of the ovarian-adenocarcinoma cell line IGROV1. Int J Cancer. 1995;63:530-6.
58. Chishti AH, Kim AC, Marfatia SM, Lutchman M, Hanspal M, Jindal H, et al. The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci. 1998;23:281-2.
59. Takeshita H, Kusuzaki K, Ashihara T, Gebhardt MC, Mankin HJ, Hirasawa Y. Actin organization associated with the expression of multidrug resistant phenotype in osteosarcoma cells and the effect of actin depolymerization on drug resistance. Cancer Lett. 1998;126:75-81.
60. Puddu P, Fais S, Luciani F, Gherardi G, Dupuis ML, Romagnoli G, et al. Interferon-gamma up-regulates expression and activity of P-glycoprotein in human peripheral blood monocyte-derived macrophages. Lab Invest. 1999;79:1299-309.
61. Fu D, Roufogalis BD. Actin disruption inhibits endosomal traffic of P-glycoprotein-EGFP and resistance to daunorubicin accumulation. Am J Physiol Cell Physiol. 2007;292:C1543-52.
62. Brambilla D, Zamboni S, Federici C, Lugini L, Lozupone F, Milito AD, et al. P-glycoprotein binds to ezrin at amino acid residues 149-242 in the FERM domain and plays a key role in the multidrug resistance of human osteosarcoma. Int J Cancer. 2012;130:2824-34.
63. Birch M, Mitchell S, Hart IR. Isolation and characterization of human melanoma cell variants expressing high and low levels of CD44. Cancer Res. 1991;51:6660-7.
64. Bartolazzi A, Peach R, Aruffo A, Stamenkovic I. Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development. J Exp Med. 1994;180:53-66.
65. Legg JW, Isacke CM. Identification and functional analysis of the ezrin-binding site in the hyaluronan receptor, CD44. Curr Biol. 1998;8:705-8.
66. Colone M, Calcabrini A, Toccacieli L, Bozzuto G, Stringaro A, Gentile M, et al. The multidrug transporter P-glycoprotein: a mediator of melanoma invasion? J Invest Dermatol. 2007; 128:957-71.
67. Jaiswal R, Raymond Grau GE, Bebawy M. Cellular communication via microparticles: role in transfer of multidrug resistance in cancer. Future Oncol. 2014;10:655-69.
68. Mizejewski GJ. Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med. 1999;222:124-38.
69. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell. 2002;110:673-87.
70. Montanez E, Ussar S, Schifferer M, Bösl M, Zent R, Moser M, et al. Kindlin-2 controls bidirectional signaling of integrins. Genes Dev. 2008;22:1325-30.
71. Saiki I, Yoneda J, Azuma I, Fujii H, Abe F, Nakajima M, et al. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradationm. Int J Cancer. 1993;54:137-43.